Galantos Pharma

BiotechnologySeries CMainz, Germanygalantos.com

Latest round

Series C

Last raised

Mar 2010

Total raised

$10M

Investors

4

About Galantos Pharma

Galantos Pharma is a biopharmaceutical company focused on the research and development of novel drugs for the treatment of neurodegenerative diseases, in particular Alzheimer‘s Disease (AD).

Who invested in Galantos Pharma

4 investors across 3 rounds

See all investors in Galantos Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Mar 16, 2010

    Amount

    $6M

    Investors

    Locked

  2. Series B

    Jul 31, 2007

    Amount

    $3.8M

    Investors

    Locked

  3. Series A

    Mar 7, 2006

    Amount

    $0.7M

    Investors

    Locked

Questions about Galantos Pharma

Who invested in Galantos Pharma?

Galantos Pharma has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Galantos Pharma raised?

Galantos Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Galantos Pharma last raise money?

Galantos Pharma's most recent round on record is a Series C, in Mar 2010.

What does Galantos Pharma do?

Galantos Pharma is a biopharmaceutical company focused on the research and development of novel drugs for the treatment of neurodegenerative diseases, in particular Alzheimer‘s Disease (AD).

Where is Galantos Pharma headquartered?

Galantos Pharma is headquartered in Mainz, Germany.

Which VCs invest in companies like Galantos Pharma?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Galantos Pharma's stage. Their profiles are linked below.

Raising like Galantos Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.